These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 7105517)

  • 21. Adjuvant chemotherapy in the primary management of breast cancer.
    Fisher B
    Med Clin North Am; 1977 Sep; 61(5):953-65. PubMed ID: 330977
    [No Abstract]   [Full Text] [Related]  

  • 22. Multimodal therapy for histological stage-II breast cancer. Multicentre Breast Cancer Chemotherapy Group.
    Lancet; 1977 Aug; 2(8034):396-7. PubMed ID: 70600
    [No Abstract]   [Full Text] [Related]  

  • 23. Treatment of advanced breast cancer with aminoglutethimide--response after previous tamoxifen treatment.
    Bezwoda WR; Derman DP; Browde S; Goss G; Lange M
    S Afr Med J; 1984 Sep; 66(10):372-4. PubMed ID: 6484759
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Editorial: Major advance in breast-cancer therapy.
    Holland JF
    N Engl J Med; 1976 Feb; 294(8):440-1. PubMed ID: 1246311
    [No Abstract]   [Full Text] [Related]  

  • 25. Response to secondary therapy in patients with adenocarcinoma of the breast previously treated with adjuvant chemotherapy.
    Bitran JD; Desser RK; Shapiro CM; Michel A; Kozloff MF; Billings AA; Recent W
    Cancer; 1983 Feb; 51(3):381-4. PubMed ID: 6821824
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Breast cancer chemotherapy: perioperative considerations in breast reconstruction.
    Gargan TJ; Come SE; Satwicz PR
    Plast Reconstr Surg; 1985 Mar; 75(3):430-4. PubMed ID: 3919414
    [No Abstract]   [Full Text] [Related]  

  • 27. Endocrine factors in the outcome of systemic adjuvant therapy of early breast cancer.
    Bianco AR; De Placido S; Perrone F; Carlomagno C; De Laurentiis M; Del Mastro L; Lauria R; Marinelli A; Gallo C
    Ann N Y Acad Sci; 1993 Nov; 698():330-8. PubMed ID: 8279772
    [No Abstract]   [Full Text] [Related]  

  • 28. [Adjuvant therapy of breast cancer].
    Semiglazov VF; Abzumanov AS; Bozhok AA; Ivanov VG; Ivanova OA; Barash NIu; Topuzov EE; Seleznev IK; Migmanova NSh; Popova RT; Nurgaziev KSh
    Khirurgiia (Mosk); 2001; (5):52-60. PubMed ID: 11505673
    [No Abstract]   [Full Text] [Related]  

  • 29. Chemotherapy in the treatment strategy of breast cancer.
    Carbone PP
    Cancer; 1975 Aug; 36(2):633-7. PubMed ID: 1157025
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Management of advanced breast cancer in post-menopausal women. A comparative trial of hormonal therapy, chemotherapy, and a combination of both].
    Clavel B; Cappelaere JP; Guerin J; Klein T; Pommatau E; Berlie J
    Sem Hop; 1982 Sep; 58(34):1919-23. PubMed ID: 6293073
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Adjuvant chemotherapy in operable breast cancer].
    Senn HJ
    Dtsch Med Wochenschr; 1984 Jun; 109(26):1034-43. PubMed ID: 6734462
    [No Abstract]   [Full Text] [Related]  

  • 32. [Hormone therapy of patients with breast cancer].
    Moiseenko VM; Semiglazov VF
    Vopr Onkol; 1984; 30(11):3-9. PubMed ID: 6393574
    [No Abstract]   [Full Text] [Related]  

  • 33. Adjuvant therapy with tamoxifen in operable breast cancer. 10 year results of the Naples (GUN) study.
    Bianco AR; De Placido S; Gallo C; Pagliarulo C; Marinelli A; Petrella G; D'Istria M; Delrio G
    Lancet; 1988 Nov; 2(8620):1095-9. PubMed ID: 2903322
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adjuvant systemic therapy for women with node-positive breast cancer. The Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer.
    CMAJ; 1998 Feb; 158 Suppl 3():S52-64. PubMed ID: 9484279
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The current status of systemic adjuvant therapy in the management of primary breast cancer.
    Fisher B; Wolmark N
    Surg Clin North Am; 1981 Dec; 61(6):1347-60. PubMed ID: 7031938
    [No Abstract]   [Full Text] [Related]  

  • 36. [Value of hormone therapy in metastasizing breast cancer].
    Samonigg H
    Wien Med Wochenschr; 1985 Dec; 135(23-24):602-7. PubMed ID: 2937208
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Favorable factors in the adjuvant therapy of breast cancer.
    Carpenter JT; Maddox WA; Laws HL; Wirtschafter DD; Soong SJ
    Cancer; 1982 Jul; 50(1):18-23. PubMed ID: 7044517
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alternating cyclical hormonal-cytotoxic combination chemotherapy in postmenopausal patients with breast cancer. An EORTC trial.
    Heuson JC; Sylvester R; Engelsman E
    Eur J Cancer (1965); 1980; Suppl 1():113-7. PubMed ID: 7032920
    [No Abstract]   [Full Text] [Related]  

  • 39. Symposium on breast carcinoma.
    Weinrach RS
    Ariz Med; 1975 Apr; 32(4):299-302. PubMed ID: 1119949
    [No Abstract]   [Full Text] [Related]  

  • 40. Tamoxifen and chemotherapy for lymph node-negative, estrogen receptor-positive breast cancer.
    Fisher B; Dignam J; Wolmark N; DeCillis A; Emir B; Wickerham DL; Bryant J; Dimitrov NV; Abramson N; Atkins JN; Shibata H; Deschenes L; Margolese RG
    J Natl Cancer Inst; 1997 Nov; 89(22):1673-82. PubMed ID: 9390536
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.